If approved by the medicines regulator Swissmedic, it would be the first protein-based vaccine to be made available in the country.
Because Novavax has no physical presence in Switzerland, it must apply for authorisation through the Swiss-based distributor Future Health.
Nuvaxovid has been approved for use in the EU by the European Medicines Agency (EMA). The Swiss application must be based on the same documents that were formerly submitted to the EMA.
The process “is intended to help ensure that medicines that are already authorised abroad can be made available to patients in Switzerland as quickly as possible”, said a Swiss government press releaseExternal link on Monday.
Nuvaxovid contains the coronavirus spike protein, which trains the body to identify the virus and swiftly produce antibodies. The vaccine can be stored in conventional fridges for up to six months.
Swissmedic has to date approved mRNA vaccines from Pfizer/BioNTech and Moderna plus the viral vector alternative from Johnson & Johnson for use in Switzerland.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
WTO improves its world trade forecast thanks to Trump’s tariffs
This content was published on
The World Trade Organisation (WTO) expects world trade to grow by 0.9% this year, better than expected in April. US imports surged in the first quarter as a result of Donald Trump's tariff announcements.
Swiss gold exports might not face US tariffs after all
This content was published on
Gold exports to the United States may not be taxed after all. The White House plans to "issue an executive order in the near future to clarify misinformation regarding the taxation of gold bullion," among other things.
Heat warning issued in western and southern Switzerland
This content was published on
With the coming days set to be hot, authorities have declared a danger level of 3 out of 5 for certain parts of the country.
Switzerland concerned by fresh Israeli plans for Gaza
This content was published on
The foreign ministry has said it is “deeply concerned” about Israel’s plans to expand military operations in the Gaza Strip.
Satellite images detect signs of Blatten landslide in 2016
This content was published on
Warning signs of the landslide that wiped out the village in May were visible from space years before, the ESA has found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland backs mRNA vaccine for booster jabs
This content was published on
Swiss teenagers, aged 12 to 15, and people who received initial doses of Janssen vector viral vaccine are advised to take a mRNA booster jab.
Covid vaccines: how to end the wait for billions of people
This content was published on
A waiver on intellectual property rights could be the key to getting more Covid drugs and vaccines to the developing world. But it's controversial.
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
Vaccine alternative has limited impact on Covid campaign
This content was published on
The offer of a non-mRNA Covid vaccine in Switzerland has failed to speed up the government’s vaccination campaign, experts say.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.